Understanding the Recent Trends in Moderna's Options Market
Understanding the Current Trends in Moderna's Options Market
Financial experts have noted a significant bullish sentiment surrounding Moderna. Our detailed analysis of the options trading history for Moderna (MRNA) has revealed 11 unusual trades that merit further examination.
In our investigation, we discovered that 45% of traders exhibited a bullish outlook, while 36% displayed bearish tendencies. Notably, among the trades analyzed, 3 were put options valued at $91,685 and 8 were call options valued at $309,766.
Market Price Target Insights
By assessing trading volumes along with Open Interest, it becomes evident that the predominate price range targeted by significant market players for Moderna is between $70.0 and $105.0 over the past three months.
Evaluation of Volume and Open Interest Trends
Currently, the average open interest for Moderna's options is recorded at 1117.73, with a total volume of 1,609.00. The corresponding data illustrates the changes in call and put option volumes as well as open interest for high-value trades focused between the $70.0 and $105.0 strike price range, observed in the previous 30 days.
Snapshot of Options Volume and Interest Over 30 Days
Highlights of Major Options Trades
The recent trading landscape for Moderna has been characterized by the following notable options transactions:
- Symbol: MRNA | Type: CALL | Trade Type: TRADE | Sentiment: BEARISH | Expiration: 09/13/24 | Price: $6.05 | Total Trade Value: $60.5K | Open Interest: 323 | Volume: 200
- Symbol: MRNA | Type: CALL | Trade Type: SWEEP | Sentiment: BEARISH | Expiration: 09/20/24 | Price: $1.87 | Total Trade Value: $46.2K | Open Interest: 1.3K | Volume: 95
- Symbol: MRNA | Type: CALL | Trade Type: SWEEP | Sentiment: BULLISH | Expiration: 09/27/24 | Price: $1.98 | Total Trade Value: $44.7K | Open Interest: 25 | Volume: 0
- Symbol: MRNA | Type: CALL | Trade Type: SWEEP | Sentiment: BULLISH | Expiration: 10/04/24 | Price: $2.99 | Total Trade Value: $39.7K | Open Interest: 14 | Volume: 210
- Symbol: MRNA | Type: PUT | Trade Type: SWEEP | Sentiment: BULLISH | Expiration: 10/18/24 | Price: $7.45 | Total Trade Value: $36.5K | Open Interest: 4.1K | Volume: 78
Overview of Moderna
Founded in 2010, Moderna is a leading commercial-stage biotechnology firm that went public in December 2018. The company's innovative mRNA technology found rapid validation with the COVID-19 vaccine, which received authorization in the United States in December 2020. As of mid-2023, Moderna has 39 mRNA development candidates under clinical trials spanning multiple therapeutic areas, including infectious diseases, oncology, cardiovascular conditions, and rare genetic disorders.
Given the insights from the recent options history, it’s essential to shift our focus towards understanding Moderna's current performance.
Current Market Position of Moderna
- The stock price of MRNA has surged by 6.71%, currently standing at $77.78 with a trading volume of 1,390,951.
- Relative Strength Indicator (RSI) metrics suggest that the stock holds a neutral position between being overbought and oversold.
- Investors can anticipate the next earnings report in approximately 52 days.
Analyst Forecasts for Moderna
In the past month, analysts have provided ratings for this stock, reflecting an average target price of $85.0.
- A JP Morgan analyst maintains a Neutral rating on Moderna, with a price target set at $88.
- Meanwhile, an analyst from HSBC upgraded their recommendation to Hold, adjusting their target price to $82.
Engaging in options trading brings with it heightened risks, but also opens the door for potential profits. Savvy investors minimize risks through continued education, strategic adjustments, and keen attention to market trends. Stay informed on the latest developments surrounding Moderna's option trades.
Frequently Asked Questions
What unusual trades were noted for Moderna?
Analysis revealed 11 unusual trades, with 45% bullish and 36% bearish outlooks.
What is the price range targeted by traders?
Traders primarily focus on a price band between $70.0 and $105.0 for Moderna.
What does the current open interest indicate?
The average open interest stands at 1117.73, highlighting investor engagement.
How has Moderna performed recently?
Moderna's stock is up 6.71% with a current price of $77.78.
What are the analyst ratings for Moderna?
Recent ratings suggest an average target price of $85.0, with updates from JP Morgan and HSBC.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Innovative Leadership: Elevate's Brian Strom Recognized
- HSBC Encourages Equity Investments Amid Market Pullback
- Soil Testing Equipment Market Trends and Growth Insights
- Exploring the Growth of Natural Language Generation Market
- Manga Market Growth Projected at USD 66 Billion by 2033
- Pharmaceutical Intermediates Market: Future Growth Insights
- Growth Forecast of the InGaAs Camera Market Through 2033
- Exploring Psychedelics: Insights from Mycopreneur Dennis Walker
- Estee Lauder's Options Activity: Insights and Market Trends
- What Investors Are Focusing On for SoFi Technologies
Recent Articles
- Harvard Business Review Hosts Its Future of Business Conference
- Understanding Market Trends: Affirm Holdings Options Insights
- Exploring Recent Market Trends in JPMorgan Chase Options
- SolaREIT Secures Innovative Debt Solution for Clean Energy Growth
- FDA Approves Rezolute's Breakthrough Treatment for Genetic Illness
- Banxso Forms Exciting New Partnership with QPR Football Club
- Investors Target Five Below, Inc. (NASDAQ: FIVE) in Class Action
- ParkerVision Prevails Against Qualcomm in U.S. Federal Court
- SolaREIT Unveils Strategic Debt Facility for Renewable Energy
- Cahill Gordon Welcomes Dan Amato as Partner in Private Credit
- Argentina's Inflation Drop: A Sign of Economic Shifts
- Evercore ISI Adjusts Outlook on Google Amid Legal Challenges
- Tesla and Nvidia Drive Stock Market Dynamics This Week
- Exploring Low-Beta Stocks for a Resilient Investment Strategy
- Understanding Dave Ramsey's Approach to Real Estate Rentals
- Vehicle-to-Grid Market Set to Surpass $3.6 Billion by 2032
- Rising Demand Drives Global Growth in Tamper Proof Packaging
- Moderna, Inc. Class Action: Important Details to Note
- What Endava plc Shareholders Must Know About Their Rights
- Vestian's Bold New Identity Reflects Global Growth and Vision
- Understanding the Recent Class Action Against MongoDB, Inc.
- Temple OrthoBiologics Aims to Revolutionize Sports Medicine
- Experience Elevated Dining at Blue Anchor Bar + Kitchen
- Shareholders Urged to Act: Walgreens Boots Alliance Faces Lawsuit
- Discover the Impressive Returns on Apollo Global Management Over a Decade
- Leadership Changes at Preston Hollow Enhance Growth Potential
- GAME READY® Partners with NFL Star Nick Bosa for Recovery Tech
- Transforming $100 Into $6,700: A Journey with TYL
- Celebrating Family and Culture: ¡Hola Cine! Screening Event
- Constructor Secures Spot in Will Reed's Top 100 for 2024
- Palantir Technologies Thrives with S&P 500 Inclusion and AI Innovations
- Investors Rally Against American Airlines for Security Violations
- Discover the Transformative Power of Long-Term Investments
- Savvas Introduces Innovative AI Tools for Educators and Students
- Transforming $1,000 into $8,750: Discover Finl's Journey
- Surging Growth in Cardiac Tissue Engineering to USD 1.3 Billion by 2029
- Leqembi: A New Hope for Alzheimer’s Patients in Treatment Journey
- WiMi Unveils Blockchain-Based Learning Framework for AI Models
- Builders Earn Recognition as a Top Employer in Insurance Sector
- Investors Urged to Join CAE Class Action Before Deadline
- Important Shareholder Information for CVS Health Corporation
- Important Information for Verve Therapeutics Shareholders
- Investors Urged to Act: Arbor Realty Trust Class Action Insights
- Accenture and 6clicks Create New Standards in Cyber GRC
- Beyond Identity: A Leader in Security Innovation and Growth
- Shareholders Urged to Act Before Lead Plaintiff Deadline in XPEL Case
- QBE North America Extends Challenge Grant for Blue Forest
- New Seafood Dining Experience Launches at Blue Anchor Bar
- Public Companies Face $3 Million in SEC Penalties for Violations
- US Stocks See Recovery Amid Economic Uncertainty and Labor Dynamics